Stock listing
OTC:BLCM Bellicum Pharmaceuticals Inc Stock
Follow Bellicum Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted OTC:BLCM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:BLCM
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Bellicum Pharmaceuticals Inc on 6ix
- Decks
- 9 decks · latest Dec 6, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2021) | Investor deck | 28 slides | Dec 6, 2021 |
| Investor Presentation (September 2021) | Investor deck | 28 slides | Sep 13, 2021 |
| Investor Presentation (February 2021) | Investor deck | 25 slides | Feb 9, 2021 |
| Investor Presentation (October 2020) | Investor deck | 26 slides | Oct 29, 2020 |
| Investor Presentation (January 2020) | Investor deck | 29 slides | Jan 15, 2020 |
| Investor Presentation (July 2019) | Investor deck | 29 slides | Jul 29, 2019 |
| Investor Presentation (June 2019) | Investor deck | 31 slides | Jun 4, 2019 |
| Investor Presentation (June 2019) | Investor deck | 30 slides | Jun 3, 2019 |
| Investor Presentation (March 2019) | Investor deck | 33 slides | Mar 13, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stephen Davis Other companies: ACADIA Pharmaceuticals Inc. (CEO, Director · Jul 15, 2014 – Aug 16, 2024 · Past); Furiex Pharmaceuticals Inc (Director · May 24, 2013 – Jul 2, 2014 · Past); Ardea Biosciences Inc (EVP & COO · Apr 6, 2010 – Jun 19, 2012 · Past); Heron Therapeutics, Inc. (Director · Feb 17, 2010 – Dec 16, 2022 · Past); Synageva BioPharma Corp (Director · Jun 27, 2007 – Jun 22, 2015 · Past); Neurogen Corp (President, CEO, Director · Dec 15, 2006 – Jul 25, 2008 · Past) | Director · Jul 13, 2015 – Jan 3, 2023 · Past |
| Alan A Musso Other companies: Research Alliance Corporation IV (Director · Since at least Jul 10, 2026); Rein Therapeutics, Inc. (Director · Since at least Oct 31, 2023); Fulcrum Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 7, 2023); Gyre Therapeutics, Inc. (SVP, Fin+Admin, CFO & Treas · Apr 11, 2006 – Oct 17, 2014 · Past) | CFO and Treasurer · Dec 17, 2014 – Jul 2, 2018 · Past |
| Edmund Harrigan Other companies: Incyte Corporation (Director · Since at least Dec 16, 2019); ACADIA Pharmaceuticals Inc. (Director · Since at least Nov 25, 2015); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Aug 12, 2020 · Past); PhaseBio Pharmaceuticals Inc (Director · Dec 13, 2018 – May 19, 2023 · Past) | Director · Feb 20, 2018 – Jun 13, 2019 · Past |
| Reid Huber Other companies: Rapport Therapeutics, Inc. (Partner, Third Rock Ventures · Since at least Jun 6, 2024); CARGO Therapeutics, Inc. (Director · Since at least Nov 9, 2023); Tango Therapeutics, Inc. (Director · Aug 10, 2021 – Jun 6, 2023 · Past); Incyte Corporation (EVP, Chief Scientific Officer · Apr 27, 2014 – Jul 16, 2018 · Past) | Director · Dec 17, 2014 – Jan 3, 2023 · Past |
| Atabak Mokari Other companies: Corcept Therapeutics Incorporated (Chief Financial Officer · Since at least Mar 1, 2021); IRIDEX Corporation (CFO and VP Corp Development · Jul 11, 2016 – Nov 24, 2018 · Past) | Chief Financial Officer · Dec 19, 2018 – Apr 8, 2020 · Past |
| Richard A Fair Other companies: Enliven Therapeutics, Inc. (PRESIDENT AND CEO, Director · Since at least Dec 11, 2025); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past) | President and CEO, Director · Jan 30, 2017 – Aug 15, 2022 · Past |
| David Eric Strauss Other companies: Terns Pharmaceuticals, Inc. (Principal Accounting Officer · Feb 1, 2025 – Feb 1, 2025 · Past) | Sr Director, Corp Controller · Jan 8, 2020 – Dec 15, 2020 · Past |
| Judith Klimovsky Other companies: Bio-Techne Corp (Director · Since at least Apr 24, 2024) | Director · Dec 20, 2018 – Jan 3, 2023 · Past |
| Ken Moseley Other companies: Marker Therapeutics, Inc. (General Counsel · Dec 21, 2018 – Dec 21, 2018 · Past) | Sr. VP and General Counsel · Dec 17, 2014 – Jan 3, 2018 · Past |
| Alan K Smith | EVP, Technical Operations · May 10, 2017 – Apr 8, 2020 · Past |
All 14 people
| Person | Seat |
|---|---|
| Annemarie Moseley | COO/EVP Clinical Development · Dec 17, 2014 – Jan 3, 2017 · Past |
| Charles S Grass | Principal Accounting Officer · May 11, 2021 – May 11, 2021 · Past |
| Frank B McGuyer | Director · Jun 15, 2016 – Jun 14, 2018 · Past |
| Rosemary Y Williams | VP, Finance & PAO · Aug 16, 2018 – Jan 2, 2020 · Past |
Log in to ask 6ix AI your own questions about Bellicum Pharmaceuticals Inc.